跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 214 条关于
“PfGARP”
全部
214
临床试验
147
药物
29
机构
0
资讯
38
2个月前
FAU Joins $3.8M NIH-Funded Consortium to Develop Novel Antimalarial Drugs Targeting PfGARP
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
12年前
Niraparib Maintenance Therapy Demonstrates Sustained Benefit in Recurrent Ovarian Cancer
4年前
PARP Inhibitors Show Promise in Ovarian Cancer Maintenance Therapy
去年
PARP Inhibitor Niraparib Shows Breakthrough Results in Mesothelioma Treatment
去年
Genomic Scarring Score Predicts PARP Inhibitor Response in NSCLC
去年
GSK's PARP Drug Zejula Approved for Wider Ovarian Cancer Population
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
4年前
Advances in PARP Inhibitor Combinations Show Promise for Ovarian Cancer Treatment
第 1 页,共 4 页
上一页
下一页